Hjem › Kreft (alle typer) › Missouri › Springfield
Kliniske studier for Kreft (alle typer) i Springfield, MO
10 studier for Kreft (alle typer) søker deltakere på steder i og rundt Springfield (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 3
- Hulston Cancer Center /ID# 232226, Springfield
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Oncology Hematology Associates, Springfield
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
RekruttererObservasjonsstudie
- Oncology Hematology Associates, Springfield
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- Mercy Hospital Springfield, Springfield
- CoxHealth South Hospital, Springfield
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
RekruttererObservasjonsstudie
- Mercy Hospital - SPG, Springfield
Galleri® in the Medicare Population.
RekruttererFrivillige helsepersonell ønskes velkommen
- Mercy Health - Springfield, Springfield
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
RekruttererObservasjonsstudie
- Oncology Hematology Associates, Springfield
GEMINI-NSCLC: NSCLC Biomarker Study
RekruttererObservasjonsstudie
- Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center, Springfield
- Oncology Hematology Associates, Springfield
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
RekruttererObservasjonsstudie
- Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center, Springfield
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutterer
- Cox South Hospital, Springfield
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY110 studier
- Boston, MA86 studier
- Los Angeles, CA73 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Durham, NC58 studier
- Washington, DC58 studier
- Chicago, IL51 studier
- Seattle, WA49 studier
- Atlanta, GA49 studier
- Arlington, VA48 studier
Andre studier i Springfield
- Kolorektal kreft11 studier
- Ikke-småcellet lungekreft10 studier
- Brystkreft10 studier
- Overvekt7 studier
- Fedme7 studier
- Metastatisk kreft6 studier
- Melanom6 studier
- Lungekreft6 studier
- Eggstokkreft5 studier
- Tykktarmskreft5 studier
- Prostatakreft4 studier
- Blærekreft4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.